Core Viewpoint - Shanghai Miaokelan Food Technology Co., Ltd. disclosed the resolutions from the 14th meeting of the 12th Board of Directors, which included the approval of the Q3 2025 report and a proposal for cash management of idle funds [1][3][4]. Meeting Legitimacy - The meeting was legally valid, with all nine directors present, meeting the legal requirements as per the Company Law and Articles of Association [2]. Resolutions Passed - The Q3 2025 report was approved unanimously with 9 votes in favor, having been previously reviewed by the audit committee [3]. - A proposal for cash management using idle self-owned and raised funds was also unanimously approved, with details available in the company's announcements [4]. Investor Information - Investors can access detailed information about the resolutions and the company's latest operational and financial arrangements through designated disclosure channels [5].

Group 1 - The board of directors of Zhejiang Lino Fluid Control Technology Co., Ltd. held its 12th meeting of the 5th session on October 27, 2025, with all 7 directors present, including one independent director attending via communication [2][5] - The meeting was convened in accordance with the relevant regulations of the Company Law of the People's Republic of China and the company's articles of association [2] - The board approved the proposal regarding the "2025 Third Quarter Report," which accurately reflects the company's financial status, operating results, and cash flow for the first nine months of 2025 [3][4] Group 2 - The proposal was reviewed and approved by the company's audit committee prior to the board meeting [4] - The voting results showed unanimous support with 7 votes in favor, 0 against, and 0 abstentions [5] - This proposal does not require submission for shareholder meeting approval [6]

Core Points - The company Inner Mongolia Furui Medical Technology Co., Ltd. (stock code: 300049) held its 15th meeting of the 8th Board of Directors on October 28, 2025, where two resolutions were passed unanimously [1] - The resolutions included the approval of the Q3 2025 report and amendments to the independent director working rules, aimed at enhancing corporate governance [1][2] Summary by Sections Board Meeting - The board meeting was conducted via electronic means with all five directors participating, resulting in a unanimous vote of 5 in favor, 0 against, and 0 abstentions [1] - The meeting was chaired by Chairman Wang Guan, and the notice was sent out on October 22 [1] Q3 2025 Report - The Q3 2025 report was disclosed on the same day as the board meeting, providing investors with the latest operational performance data [1] Independent Director Working Rules - The amendments to the independent director working rules were made to align with the latest revisions of the company's articles of association and comply with relevant laws and regulations [1] - The revised rules were also disclosed on the same platform, ensuring transparency [1][2]

Group 1 - The company held its 12th board meeting on October 24, 2025, via communication methods, with all 7 participating directors present, ensuring compliance with relevant laws and regulations [2] - The board reviewed and approved the proposal regarding the company's Q3 2025 report, which reflects the actual operating conditions for the first three quarters of 2025, with unanimous support from the directors [2] - The detailed content of the Q3 2025 report was disclosed on the same day through designated media [3] Group 2 - The meeting's resolutions, signed and sealed by the participating directors, along with the audit committee's decision from the 4th meeting of the 12th board, are available for review [4]